Polyomavirus-Associated Nephropathy disease: Malacards - Research Articles, Drugs, Genes, Clinical Trials

MCID: PLY179 MIFTS: 24	Polyomavirus-Associated Nephropathy Categories: Infectious diseases, Nephrological diseases
Genes Tissues Related diseases Publications Drugs Expand all tables

Sources

Aliases & Classifications for Polyomavirus-Associated Nephropathy

MalaCards integrated aliases for Polyomavirus-Associated Nephropathy:

Name: Polyomavirus-Associated Nephropathy ¹² ¹⁵

Polyomavirus Associated Nephropathy ¹²

Pvan ¹²

Classifications:

MalaCards categories:
Global: Infectious diseases
Anatomical: Nephrological diseases

See all MalaCards categories (disease lists)

External Ids:

Disease Ontology ¹² DOID:0040086

UMLS ⁷⁴ C1697878

Sources

Summaries for Polyomavirus-Associated Nephropathy

Disease Ontology : ¹² A viral infectious disease has material basis in BK polyomavirus.

MalaCards based summary : Polyomavirus-Associated Nephropathy, also known as polyomavirus associated nephropathy, is related to kidney disease and hematopoietic stem cell transplantation. An important gene associated with Polyomavirus-Associated Nephropathy is STX18 (Syntaxin 18). The drugs Vitamin D3 and Vitamin D have been mentioned in the context of this disorder. Affiliated tissues include kidney, bone and pancreas.

Sources

Related Diseases for Polyomavirus-Associated Nephropathy

Diseases related to Polyomavirus-Associated Nephropathy via text searches within MalaCards or GeneCards Suite gene sharing:

#	Related Disease	Score	Top Affiliating Genes
1	kidney disease	10.5
2	hematopoietic stem cell transplantation	10.0

Sources

Symptoms & Phenotypes for Polyomavirus-Associated Nephropathy

Sources

Drugs & Therapeutics for Polyomavirus-Associated Nephropathy

Drugs for Polyomavirus-Associated Nephropathy (from DrugBank, HMDB, Dgidb, PharmGKB, IUPHAR, NovoSeek, BitterDB):

(show all 16)

Name

Status

Phase

Clinical Trials

Cas Number

PubChem Id

Vitamin D3

Approved, Nutraceutical

Phase 4

67-97-0

5280795 6221

Synonyms:

()-Vitamin D3

(+)-vitamin D3

(+)-Vitamin D3

(1S,3Z)-3-[(2E)-2-[(1R,3AR,7as)-7a-methyl-1-[(2R)-6-methylheptan-2-yl]-2,3,3a,5,6,7-hexahydro-1H-inden-4-ylidene]ethylidene]-4-methylidene-cyclohexan-1-ol

(3 beta,5Z,7E)-9,10-Secocholesta-5,7,10(19)-trien-3-ol

(3b,5Z,7E)-9,10-Secocholesta-5,7,10(19)-trien-3-ol

(3beta,5Z,7E)-9,10-secocholesta-5,7,10(19)-trien-3-ol

(3beta,5Z,7E)-9,10-Secocholesta-5,7,10(19)-trien-3-ol

(3S,5Z,7E)-9,10-secocholesta-5,7,10(19)-trien-3-ol

(3β,5Z,7E)-9,10-secocholesta-5,7,10(19)-trien-3-ol

(3Β,5Z,7E)-9,10-secocholesta-5,7,10(19)-trien-3-ol

(5Z,7E)-(3S)-9,10-seco-5,7,10(19)-cholestatrien-3-ol

(5Z,7E)-(3S)-9,10-secocholesta-5,7,10(19)-trien-3-ol

(5Z,7E)-(3S)-9,10-Secocholesta-5,7,10(19)-trien-3-ol

1406-16-2

25(OH)D

47763_SUPELCO

57651-82-8

67-97-0

7-DEHYDROCHOLESTEROL

7-Dehydrocholesterol activated

7-Dehydrocholesterol, Activated

7-Dehydrocholesterol, irradiated

7-Dehydrocholestrol, activated

8024-19-9

8050-67-7

89193_FLUKA

9,10-Seco(5Z,7E)-5,7,10(19)-cholestatrien-3beta-ol

9,10-Seco(5Z,7E)-5,7,10(19)-cholestatrien-3-ol

9,10-Secocholesta-5(Z),7(E),10(19)-trien-3(.beta.)-ol

9,10-Secocholesta-5,7,10(19)-trien-3-beta-ol

AB1002422

AC-11697

AC1L1ECK

AC1L1M23

AC1LU7IZ

AC1NQXLN

AC1NR2UO

AC1NR2UR

AC1NR2UU

AC1NS4AJ

AC1NSHJX

AC1O5EOF

AC1O7GAV

AC1O7GQ3

AC1O8FEU

AC1O8PWJ

AC1OF2GI

AC1OF2GL

AC1OIEW5

AC1OIEWB

ACon1_001997

ACTIVATED

Activated 7-dehydrocholesterol

Arachitol

Bio-0845

bmse000507

BPBio1_000460

BSPBio_000418

BSPBio_002408

C05443

C1357_SIAL

C27H44O

C9756_SIGMA

C9774_SIAL

Calciol

CAS-67-97-0

CCRIS 5813

CCRIS 6286

CHEBI:283119

CHEBI:28940

CHEMBL1042

CHEMBL432780

cholecalciferol

Cholecalciferol

Cholecalciferol (D3)

Cholecalciferol (JP15/USP)

Cholecalciferol [USAN:BAN:JAN]

Cholecalciferol, D3

Cholecalciferols

Cholecalciferolum

CID10000117

CID10045875

CID10340013

CID10883523

CID10894379

CID11014566

CID11025493

CID11058152

CID11463269

CID1548921

CID2735

CID5280795

CID5283710

CID5283711

CID5283712

CID5353527

CID5363362

CID6221

CID6432644

CID6604201

CID6604662

CID6708595

CID6713938

CID6992015

CID6992016

CID7067439

CID7067440

CID7251172

CID7251174

CID9821465

Colecalciferol

Colecalciferol (INN)

Colecalciferolo

Colecalciferolo [DCIT]

Colecalciferolum

Colecalciferolum [INN-Latin]

Colecalcipherol

D00188

D3-Vicotrat

D3-Vigantol

DB00169

Delsterol

Delta-D

Delta-D (TN)

Deparal

Dihydrocholesterol

DivK1c_006276

Duphafral D3 1000

Ebivit

EINECS 200-673-2

EINECS 215-797-2

EPA Pesticide Chemical Code 202901

FeraCol

HMS1569E20

HMS2092M12

HSDB 820

I05-0041

Irradiated 7-dehydrocholesterol

KBio1_001220

KBio2_001643

KBio2_004211

KBio2_006779

KBio3_001628

KBioGR_001602

KBioSS_001643

LMST03020001

LMST03020219

LMST03020220

LMST03020221

LS-1570

LS-825

LT00244775

MEGxm0_000458

Micro-dee

MolPort-001-740-051

MolPort-001-785-972

MolPort-003-666-021

MolPort-004-946-964

NCGC00016301-01

NCGC00017328-01

NCGC00091072-01

NCGC00142511-01

NCGC00159331-02

NCGC00159331-04

NCGC00178668-01

NCGC00179565-01

NCGC00179565-02

NEO Dohyfral D3

NSC 375571

NSC375571

NSC-375571

Oleovitamin D3

Prestwick_63

Prestwick0_000429

Prestwick1_000429

Prestwick2_000429

Prestwick3_000429

Provitamine

Provitina

Rampage

Ricketon

SMP1_000068

SPBio_001298

SPBio_002357

SpecPlus_000180

Spectrum_001163

Spectrum2_001369

Spectrum3_000764

Spectrum4_001201

SR-05000001559

SR-05000001559-3

ST057172

TNP00266

Trivitan

UNII-1C6V77QF41

UPCMLD-DP152

UPCMLD-DP152:001

Vi-de-3-hydrosol

Vigorsan

VITAMIN D

Vitamin D 3

vitamin d-3

Vitamin D3

Vitamin D-3

Vitamin D3 emulsifiable

VITAMIN D3 POWDER

VITAMIN_D3

Vitinc Dan-Dee-3

ZINC04474460

ZINC04492874

ZINC04492875

ZINC04492876

ZINC04492878

δ-D

Vitamin D

Approved, Nutraceutical, Vet_approved

Phase 4

1406-16-2

Calcium

Approved, Nutraceutical

Phase 4

7440-70-2

271

Synonyms:

Blood coagulation factor XIII

Ca(2+)

Ca2+

Calcio

Calcium

Calcium element

CALCIUM ion

Calcium, doubly charged positive ion

Calcium, elemental

Coagulation factor XIII

Elemental calcium

Factor XIII

Factor XIII a chain

Factor XIII a-chain

Factor XIII transamidase

Factor XIII, coagulation

Fibrin stabilizing factor

Fibrinase

Kalzium

Laki lorand factor

Laki-lorand factor

Stabilizing factor, fibrin

Transamidase, factor XIII

XIII, coagulation factor

Ergocalciferol

Approved, Nutraceutical

Phase 4

50-14-6

5280793

Synonyms:

(+)-Vitamin D2

(3b,5Z,7E,22E)-9,10-Secoergosta-5,7,10(19),22-tetraen-3-ol

(3beta,5Z,7E,22E)-9,10-secoergosta-5,7,10(19),22-tetraen-3-ol

(3beta,5Z,7E,22E)-9,10-Secoergosta-5,7,10(19),22-tetraen-3-ol

(3-beta,5Z,7E,22E)-9,10-Secoergosta-5,7,10,(19),22-tetraen-3-ol

(3S,5Z,7E,14xi,17alpha,22E)-9,10-secoergosta-5,7,10,22-tetraen-3-ol

(3S,5Z,7E,22E)-9,10-secoergosta-5,7,10(19),22-tetraen-3-ol

(3S,5Z,7E,22E)-9,10-secoergosta-5,7,10,22-tetraen-3-ol

(3β,5Z,7E,22E)-9,10-secoergosta-5,7,10(19),22-tetraen-3-ol

(5E,7E,22E)-9,10-Secoergosta-5,7,10,22-tetraen-3-ol

(5Z,7E,22E)-(3S)-9,10-seco-5,7,10(19),22-ergostatetraen-3-ol

(5Z,7E,22E)-(3S)-9,10-seco-5,7,10(19),22-Ergostatetraen-3-ol

(5Z,7E,22E)-(3S)-9,10-secoergosta-5,7,10(19),22-tetraen-3-ol

(5Z,7E,22E)-(3S)-9,10-Secoergosta-5,7,10(19),22-tetraen-3-ol

22-Tetraen 3beta 9,10,secoergosta-5,7,10(19)-ol

31316-19-5

47768_SUPELCO

4-Methylene-3-[2-[tetrahydro-7a-methyl-1-(1,4,5-trimethyl-2-hexenyl)-4(3ah)-indanylidene]ethylidene]-cyclohexanol

50-14-6

7489-18-1

7E677DC1-E1C4-4FC5-8F4A-BCE1857F7E87

8017-28-5

9,10,Secoergosta-5,7,10(19),22-tetraen 3.beta.-ol

9,10-Seco(5Z,7E,22E)-5,7,10(19),22-ergostatetraen-3-ol

9,10-Secoergosta-5,7,10(19),22-tetraen-3-beta-ol

9,10-Secoergosta-5,7,10(19),22-tetraen-3b-ol

95220_FLUKA

95220_SIGMA

AC-1355

AC1L1FIE

AC1NQXLH

AC1NS4DE

AC1NS9GI

AC1NSSVD

AC1NWAM3

AC1O5EDK

AC1O6WAM

ACon1_002187

Activated ergosterol

beta-Ol

bmse000510

BPBio1_000418

BSPBio_000380

BSPBio_001974

buco-D

Buco-D

C05441

C28H44O

Calciferol

Calciferol (TN)

Calciferol (vitamin D2)

CALCIFEROL IN A GELATIN MATRIX

CALCIFEROL, U.S.P.

Calciferols

Calciferolum

Calciferon 2

CHEBI:28934

CHEMBL1536

CID11003810

CID3249

CID5280793

CID5315257

CID5353610

CID5356615

CID5702050

CID6432478

CID6536972

component of Geltabs Vitamin D

Condacaps

Condocaps

Condol

Crtron

Crystallina

D00187

D2, Vitamin

Daral

D-Arthin

Davitamon D

Davitin

DB00153

Decaps

Dee-osterol

Dee-Osterol

Dee-ron

Dee-Ron

Dee-ronal

Dee-Ronal

Dee-roual

Dee-Roual

delta-Arthin

Deltalin

delta-Tracetten

De-rat concentrate

Deratol

Detalup

Diactol

Divit urto

Doral

Drisdol

Drisdol (TN)

D-Tracetten

E5750_SIGMA

EINECS 200-014-9

Ercalciol

ergocalciferol

Ergocalciferol

Ergocalciférol

Ergocalciferol (D2)

Ergocalciferol (JP15/USP)

Ergocalciferol [INN:BAN:JAN]

Ergocalciferol oil

Ergocalciferol: Vitamin D

Ergocalciferolo

Ergocalciferolo [DCIT]

Ergocalciferols

Ergocalciferolum

Ergocalciferolum [INN-Latin]

Ergorone

Ergosterol activated

Ergosterol irradiated

'Ergosterol irradiated'

Ergosterol, irradiated

Ertron

Fortodyl

Geltabs

Geltabs Vitamin D

Haliver

Hi-deratol

Hi-Deratol

HMS1920K20

HMS2091B19

HMS502I07

HSDB 819

Hyperkil

I05-0022

IDI1_000805

Infron

Irradiated ergosta-5,7,22-trien-3.beta.-ol

Irradiated ergosta-5,7,22-trien-3beta-ol

Irradiated ergosta-5,7,22-trien-3-beta-ol

Irradiated ergosterol

LMST03010001

LMST03010014

LS-3228

MEGxm0_000466

Metadee

Mina D2

MLS001332467

MLS001332468

MolPort-001-740-057

MolPort-001-793-930

MolPort-002-526-645

MolPort-003-666-178

MolPort-006-822-629

Mulsiferol

Mykostin

NCGC00142497-01

NCGC00179579-01

NCGC00179579-02

Novovitamin-D

NSC 62792

NSC62792

Oleovitamin D

Oleovitamin D, Synthetic

Oleovitamin D2

Osteil

Ostelin

Prestwick_554

Prestwick3_000420

Radiostol

Radstein

Radsterin

Rodine C

Rodinec

Shock-ferol

Shock-ferol sterogyl

SMR000857106

Sorex C.R

Sorex C.R.

SPECTRUM1500276

Spectrum5_000666

ST057150

Sterogyl

STOCK1N-53397

Synthetic vitamin D

Synthetic Vitamin D

UNII-VS041H42XC

Uvesterol D

Uvesterol-D

Vigantol

vio D

vio-D

Vio-D

Viostdrol

Viosterol

Viosterol in oil

Viosterol in Oil

Vitamin D 2

vitamin d-2

Vitamin D2

Vitamin- D2

VITAMIN D2

VITAMIN D2 WATER DISPERSABLE U.S.P.

Vitamin-?D2

VITAMIN_D2

Vitamina D2

Vitavel-D

WLN: L56 FYTJ A1 BY1&1U1Y1&Y1&1 FU2U- BL6YYTJ AU1 DQ

ZINC04474571

ZINC04629876

Vitamins

Phase 4

Ergocalciferols

Phase 4

Bone Density Conservation Agents

Phase 4

Hormones

Phase 4

Calcium, Dietary

Phase 4

Epoetin alfa

Phase 4

113427-24-0

Nutrients

Phase 4

Vitamin D2

Phase 4

Trace Elements

Phase 4

Micronutrients

Phase 4

Hematinics

Phase 4

Calciferol

Phase 4

Interventional clinical trials:

#	Name	Status	NCT ID	Phase	Drugs
1	Correcting Anemia and Native Vitamin D Supplementation in Kidney Transplant Recipients	Terminated	NCT01817699	Phase 4

Search NIH Clinical Center for Polyomavirus-Associated Nephropathy

Sources

Genetic Tests for Polyomavirus-Associated Nephropathy

Sources

Anatomical Context for Polyomavirus-Associated Nephropathy

MalaCards organs/tissues related to Polyomavirus-Associated Nephropathy:

⁴²

Kidney, Bone, Pancreas, Testes, Myeloid

Sources

Publications for Polyomavirus-Associated Nephropathy

Articles related to Polyomavirus-Associated Nephropathy:

(show top 50) (show all 63)

#	Title	Authors	Year
1	Persistent polyomavirus-associated nephropathy in a patient with GvHD and treatment with the JAK1/2 inhibitor ruxolitinib. ( 30349038 )	Fante MA...Plentz A	2019
2	Glomerular parietal epithelial cells infection is associated with poor graft outcome in kidney transplant recipients with BK polyomavirus-associated nephropathy. ( 30649366 )	Chen XT...Huang G	2019
3	Clinical utility of leflunomide for BK polyomavirus associated nephropathy in kidney transplant recipients: A multicenter retrospective study. ( 30730102 )	Keller N...Caillard S	2019
4	A multicenter application of the 2018 Banff Classification for BK polyomavirus-associated nephropathy in renal transplantation. ( 30896679 )	Bouatou Y...Florquin S	2019
5	Predictive Value of the Combination of Peripheral Blood Lymphocyte Count and Urinary Cytology in BK Polyomavirus-associated Nephropathy. ( 31056251 )	Masutani K...Kitazono T	2019
6	Aryl hydrocarbon receptor expression by macrophages and lymphocytes within infiltrates in BK polyomavirus associated nephropathy. ( 29305091 )	Bouatou Y...Florquin S	2018
7	BK polyomavirus microRNA expression and sequence variation in polyomavirus-associated nephropathy. ( 29518695 )	Virtanen E...Auvinen E	2018
8	Granulomatous inflammation in BK polyomavirus-associated nephropathy. ( 29863293 )	Zhang Y...Drachenberg CB	2018
9	Ultrasound findings of BK polyomavirus-associated nephropathy in renal transplant patients. ( 27342655 )	Dugo M...Maresca MC	2017
10	Stabilization of renal function after the first year of follow-up in kidney transplant recipients treated for significant BK polyomavirus infection or BK polyomavirus-associated nephropathy. ( 28207975 )	Simard-Meilleur MC...Renoult E	2017
11	A delicate balance between rejection and BK polyomavirus associated nephropathy; A retrospective cohort study in renal transplant recipients. ( 28609473 )	Gard L...Sanders JS	2017
12	Simultaneous pancreas/kidney transplant recipients present with late-onset BK polyomavirus-associated nephropathy. ( 26758790 )	Schachtner T...Reinke P	2016
13	Concurrent cytomegalovirus glomerulitis and BK polyomavirus-associated nephropathy in a kidney allograft biopsy. ( 26782090 )	Chikeka IO...Drachenberg CB	2016
14	Predominant Tubular Interleukin-18 Expression in Polyomavirus-Associated Nephropathy. ( 26863474 )	Stokman G...Florquin S	2016
15	Intragraft Antiviral-Specific Gene Expression as a Distinctive Transcriptional Signature for Studies in Polyomavirus-Associated Nephropathy. ( 27140517 )	Sigdel TK...Sarwal MM	2016
16	Significance, cytomorphology of decoy cells in polyomavirus-associated nephropathy: Review of clinical, histopathological, and virological correlates with commentary. ( 31042494 )	Chantziantoniou N...Al-Abbadi MA	2016
17	BK virus infection activates the TNFα/TNF receptor system in Polyomavirus-associated nephropathy. ( 26446017 )	Ribeiro A...W?rnle M	2016
18	Intragraft Blood Dendritic Cell Antigen-1-Positive Myeloid Dendritic Cells Increase during BK Polyomavirus-Associated Nephropathy. ( 26701980 )	Yapici ?...Florquin S	2016
19	Brincidofovir for polyomavirus-associated nephropathy after allogeneic hematopoietic stem cell transplantation. ( 25600489 )	Papanicolaou GA...Glezerman IG	2015
20	Polyomavirus-associated nephropathy in renal and simultaneous pancreas-kidney transplant recipients: report of three cases. ( 25579723 )	Cadavid D...Posada JG	2015
21	Falsely decreased ionized calcium levels in kidney transplant recipients with polyomavirus-associated nephropathy treated with leflunomide. ( 25711674 )	Verhoeven Y...Abrahams AC	2015
22	Early identification of renal transplant recipients with high risk of polyomavirus-associated nephropathy. ( 25749892 )	Teutsch K...Di Cristanziano V	2015
23	Impact of HMG-CoA reductase inhibitors on the incidence of polyomavirus-associated nephropathy in renal transplant recipients with human BK polyomavirus viremia. ( 25989423 )	Gabardi S...Tan CS	2015
24	Factors Influencing Graft Outcomes Following Diagnosis of Polyomavirus -Associated Nephropathy after Renal Transplantation. ( 26544696 )	Huang G...Chen LZ	2015
25	Treatment of Polyomavirus-Associated Nephropathy With the Association of Sirolimus and Leflunomide. ( 26643679 )	Lamarche C...Vall?e M	2015
26	Pathology of resolving polyomavirus-associated nephropathy. ( 23721552 )	Menter T...Hopfer H	2013
27	Adaptive immunity rather than viral cytopathology mediates polyomavirus-associated nephropathy in mice. ( 22420885 )	Albrecht JA...Newell KA	2012
28	Management of polyomavirus-associated nephropathy in renal transplant recipients. ( 22508181 )	Kuypers DR	2012
29	Analytical and clinical performance characteristics of the Simplexa BK virus quantitative PCR assay for the diagnosis of polyomavirus-associated nephropathy in renal transplant recipients using plasma and urine specimens. ( 22975084 )	Miller S...Wright C	2012
30	Adaptive immunity rather than viral cytopathology mediates polyomavirus-associated nephropathy in mice. ( 22994873 )	Funk GA	2012
31	Polyomavirus-associated nephropathy. ( 24175200 )	Costa C...Cavallo R	2012
32	Polyomavirus-associated nephropathy: a comparison of 2 different strategies for immunosuppression reduction. ( 21857366 )	Geetha D...Shafi T	2011
33	Polyomavirus associated nephropathy presenting five years after kidney transplantation. ( 21999857 )	Pavan M...Mehta HJ	2011
34	High incidence of malignancy in polyomavirus-associated nephropathy in renal transplant recipients. ( 20430180 )	Chen CH...Shu KH	2010
35	Polyomavirus associated nephropathy after kidney and pancreas transplantation: case report. ( 20698140 )	Gracin S...Ljubanovi? D	2010
36	Reducing immunosuppression preserves allograft function in presumptive and definitive polyomavirus-associated nephropathy. ( 21114642 )	Schaub S...Mayr M	2010
37	Evaluation of a preemptive strategy for BK polyomavirus-associated nephropathy based on prospective monitoring of BK viremia: a kidney transplantation center experience. ( 21168633 )	Renoult E...H?bert MJ	2010
38	The effect of low-dose cidofovir on the long-term outcome of polyomavirus-associated nephropathy in renal transplant recipients. ( 19059933 )	Wu SW...Lian JD	2009
39	Detection, distribution, and pathologic significance of BK virus strains isolated from patients with kidney transplants, with and without polyomavirus-associated nephropathy. ( 19415951 )	Boldorini R...Veggiani C	2009
40	Diagnostic accuracy of blood qualitative nucleic acid testing for polyomavirus-associated nephropathy in kidney recipients. ( 19444968 )	Cross NB...Craig JC	2009
41	Screening for polyomavirus associated nephropathy in renal transplantation with blood viral load measurement. ( 19559645 )	Boudreault AA...Desch?nes L	2009
42	Polyomavirus-associated nephropathy: critical issues in virological monitoring. ( 19845105 )	Cavallo R...Costa C	2009
43	A case of polyomavirus-associated nephropathy presenting late after transplantation. ( 18334968 )	Bansal S...Wiseman A	2008
44	Antiviral therapy for polyomavirus-associated nephropathy after renal transplantation. ( 18658193 )	Hilton R...Tong CY	2008
45	Low-dose cidofovir for the treatment of polyomavirus-associated nephropathy: two case reports and review of the literature. ( 19195325 )	Lamoth F...Meylan P	2008
46	Polyomavirus-associated nephropathy risk in kidney transplants: the influence of recipient age and donor gender. ( 17410099 )	Khamash HA...Griffin MD	2007
47	Polyomavirus polymerase chain reaction as a surrogate marker of polyomavirus-associated nephropathy. ( 17700158 )	Viscount HB...Smith TF	2007
48	BK virus regulatory region sequence deletions in a case of human polyomavirus associated nephropathy (PVAN) after kidney transplantation. ( 16202649 )	Azzi A...Comoli P	2006
49	Retransplantation after polyomavirus-associated nephropathy: just do it? ( 16433749 )	Hirsch HH...Ramos E	2006
50	A mouse model for polyomavirus-associated nephropathy of kidney transplants. ( 16611327 )	Han Lee ED...Larsen CP	2006

Sources

Genes for Polyomavirus-Associated Nephropathy

Genes related to Polyomavirus-Associated Nephropathy (0 elite genes):

- Elite gene

- Cancer Census gene in COSMIC

#	Symbol	Description	Category	Score	Evidence
1	STX18	Syntaxin 18	Protein Coding	16.11	DISEASES inferred ¹⁵
2	CABIN1	Calcineurin Binding Protein 1	Protein Coding	15.84	DISEASES inferred ¹⁵
3	NR2E3	Nuclear Receptor Subfamily 2 Group E Member 3	Protein Coding	15.82	DISEASES inferred ¹⁵
4	RPS15	Ribosomal Protein S15	Protein Coding	15.26	DISEASES inferred ¹⁵
5	RAB18	RAB18, Member RAS Oncogene Family	Protein Coding	15.18	DISEASES inferred ¹⁵
6	NDUFB4	NADH:Ubiquinone Oxidoreductase Subunit B4	Protein Coding	14.9	DISEASES inferred ¹⁵
7	IRF9	Interferon Regulatory Factor 9	Protein Coding	14.74	DISEASES inferred ¹⁵

Sources

Variations for Polyomavirus-Associated Nephropathy

Sources

Expression for Polyomavirus-Associated Nephropathy

Search GEO for disease gene expression data for Polyomavirus-Associated Nephropathy.

Sources

Pathways for Polyomavirus-Associated Nephropathy

Sources

GO Terms for Polyomavirus-Associated Nephropathy

Sources

Sources for Polyomavirus-Associated Nephropathy

¹ BioSystems

² BitterDB

³ CDC

⁴ Cell Signaling Technology

⁵ ClinicalTrials

⁶ ClinVar

⁷ CNVD

⁸ Cochrane Library

⁹ Cosmic

¹⁰ dbSNP

¹¹ DGIdb

¹² Disease Ontology

¹³ diseasecard

¹⁴ DiseaseEnhancer

¹⁵ DISEASES

¹⁶ DrugBank

¹⁷ EFO

¹⁸ ExPASy

¹⁹ FDA Approved Drugs

²⁰ FMA

²¹ GeneAnalytics

²² GeneCards

²³ GeneGo (Thomson Reuters)

²⁴ GeneHancer via GeneCards

²⁵ GeneReviews

²⁶ Genetics Home Reference

²⁷ GenomeRNAi

²⁸ GEO DataSets

²⁹ GO

³⁰ GTR

³¹ HGMD

³² HMDB

³³ HPO

³⁴ ICD10

³⁵ ICD10 via Orphanet

³⁶ ICD9CM

³⁷ IUPHAR

³⁸ KEGG

³⁹ LifeMap

⁴⁰ LncRNADisease

⁴¹ LOVD

⁴² MalaCards

⁴³ MedGen

⁴⁴ MedlinePlus

⁴⁵ MeSH

⁴⁶ MESH via Orphanet

⁴⁷ MGI

⁴⁸ miR2Disease

⁴⁹ NCBI Bookshelf

⁵⁰ NCI

⁵¹ NCIt

⁵² NDF-RT

⁵³ NIH Clinical Center

⁵⁴ NIH Rare Diseases

⁵⁵ NINDS

⁵⁶ Novoseek

⁵⁷ Novus Biologicals

⁵⁸ OMIM

⁵⁹ OMIM via Orphanet

⁶⁰ Orphanet

⁶¹ PathCards

⁶² PharmGKB

⁶³ PubMed

⁶⁴ PubMed Health

⁶⁵ QIAGEN

⁶⁶ R&D Systems

⁶⁷ Reactome

⁶⁸ Sino Biological

⁶⁹ SNOMED-CT

⁷⁰ SNOMED-CT via HPO

⁷¹ SNOMED-CT via Orphanet

⁷² TGDB

⁷³ Tocris

⁷⁴ UMLS

⁷⁵ UMLS via Orphanet

⁷⁶ UniProtKB/Swiss-Prot

⁷⁷ Wikipedia